You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 157 No. 7, 14 APRIL 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Age-Related Trends (1986-1993) in the Use of Thrombolytic Agents in Patients With Acute Myocardial Infarction

The Worcester Heart Attack Study

Harish Chandra, MD, MPH; Jorge Yarzebski, MD, MPH; Robert J. Goldberg, PhD; Judith Savageau, MPH; Colleen Singleton, RN; Jerry H. Gurwitz, MD; Joel M. Gore, MD

Arch Intern Med. 1997;157(7):741-746.


Abstract

Objective
To examine age-related differences and temporal trends in the use of thrombolytic therapy in a community-wide study of patients hospitalized with acute myocardial infarction (AMI) between 1986 and 1993.

Methods
All hospitals in the Worcester, Mass, metropolitan area (1990 census population, 437 000) were included. A total of 3824 patients with validated AMI categorized according to age comprised the study sample: younger than 55 years (n=577), 55 to 64 years (n=758), 65 to 74 years (n=1143), and 75 years or older (n=1346).

Results
Use of thrombolytic therapy increased during the period under study in all patients hospitalized with AMI (9% in 1986; 26% in 1993). In 1986, the majority of treated patients received streptokinase; while increases over time in the use of tissue-type plasminogen activator were noted, streptokinase remained the thrombolytic agent of choice in 1993. Marked age-related trends in the use of thrombolytic therapy were observed, with the most striking increases in the use of thrombolytic therapy over time seen in those aged 65 years or older. Between 1986 and 1993 the relative increases in the use of thrombolytic therapy were observed in the following age groups: younger than 55 years (106%), 55 to 64 years (85%), 65 to 74 years (694%), and 75 years or older (571%). Despite these encouraging trends in the use of thrombolytic therapy in older patients, after controlling for a variety of potential confounding variables elderly patients were significantly less likely to receive thrombolytic therapy during hospitalization for AMI. Compared with patients aged 75 years or older, patients younger than 55 years were 6.4 times (95% confidence interval [CI], 4.8-8.5), patients aged 55 to 64 years were 4.9 times (95% CI, 3.8-6.4), and patients aged 65 to 74 years were 3.0 times (95% CI, 2.3-3.9) significantly more likely to receive thrombolytic therapy. These differences were in part related to the proportion of patients with myocardial infarction satisfying eligibility criteria for the receipt of thrombolytic therapy; patients aged 75 years or older were significantly less likely to meet these criteria (19%) than were those younger than 55 years (49%), those aged 55 to 64 years (38%), and those aged 65 to 74 years (28%).

Conclusions
The present results show that while there have been substantial increases over time in the use of thrombolytic therapy in patients with AMI, most particularly in older individuals, the elderly remain appreciably less likely to receive these agents during hospitalization for AMI. These differences may be due to the smaller percentage of elderly patients satisfying criteria for the use of these agents compared with younger patients with coronary heart disease, as well as to a reluctance by physicians to use these agents in older patients. Continued monitoring of these trends remains important for examining changes in physicians' practice patterns regarding the use of thrombolytic therapy in this vulnerable population.

Arch Intern Med. 1997;157:741-746



Author Affiliations

From the Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Pre-Hospital Electrocardiogram and Time to Reperfusion in Patients With Acute Myocardial Infarction, 2000-2002: Findings From the National Registry of Myocardial Infarction-4
Curtis et al.
J Am Coll Cardiol 2006;47:1544-1552.
ABSTRACT | FULL TEXT  

Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey
Rosengren et al.
Eur Heart J 2006;27:789-795.
ABSTRACT | FULL TEXT  

Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction
Boucher et al.
CMAJ 2001;164:1285-1290.
ABSTRACT | FULL TEXT  

Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996
Tu et al.
CMAJ 1999;161:1257-1261.
ABSTRACT | FULL TEXT  

Health Care Providers' Perspectives on Patient Delay for Seeking Care for Symptoms of Acute Myocardial Infarction
Zapka et al.
Health Educ Behav 1999;26:714-733.
ABSTRACT  

Effect of age on outcome with primary angioplasty versus thrombolysis
Holmes et al.
J Am Coll Cardiol 1999;33:412-419.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.